5 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Sulfonylureas GLP-1 receptor ... agonists - ↓ major adverse ... #comparison #management ... endocrinology #dm2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Medication Guide Classes ... inhibitor, GLP-1 receptor ... #Mellitus #DM2 ... #Medications #pharmacology ... #comparison #table
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology ... semaglutide variety of adverse ... #Summary #DM2 # ... diabetes #endocrinology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... therapy with GLP-I receptor ... not definitively cause ... #Summary #DM2 # ... diabetes #endocrinology
Nuclear myocardial perfusion imaging (MPI) may be performed by either single-photon emission CT (SPECT) or positron
Pharmacologic stress ... significantly worse on echocardiogram ... valve area <1.0 cm2 ... non-selective adenosine receptor ... their undesirable adverse